Cargando…

A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases

OBJECTIVE: The objective of this paper is to assess the economic profile of enzyme replacement therapy (ERT) to symptomatic patients with Pompe, Fabry, Gaucher disease and Lysosomal acid lipase (LAL) deficiency. METHODS: A systematic search was performed to retrieve and critically assess economic ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsigianni, Eleni Ioanna, Petrou, Panagiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487102/ https://www.ncbi.nlm.nih.gov/pubmed/36123734 http://dx.doi.org/10.1186/s12962-022-00369-w

Ejemplares similares

Correction to: A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases
por: Katsigianni, Eleni Ioanna, et al.
Publicado: (2022)

Enzyme replacement therapy for lysosomal storage disorders in India
por: Muranjan, Mamta
Publicado: (2014)

Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases
por: Nathan, David G, et al.
Publicado: (2009)

Risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders
por: Hendriksz, Christian J., et al.
Publicado: (2018)

Low-dose Gene Therapy Reduces the Frequency of Enzyme Replacement Therapy in a Mouse Model of Lysosomal Storage Disease
por: Alliegro, Marialuisa, et al.
Publicado: (2016)

Role of the Lactide:Glycolide Ratio in PLGA Nanoparticle Stability and Release under Lysosomal Conditions for Enzyme Replacement Therapy of Lysosomal Storage Disorders
por: del Moral, Maria, et al.
Publicado: (2023)

The economics of TAVI: A systematic review
por: Petrou, Panagiotis
Publicado: (2023)

Toward Engineering the Mannose 6-Phosphate Elaboration Pathway in Plants for Enzyme Replacement Therapy of Lysosomal Storage Disorders
por: Zeng, Ying, et al.
Publicado: (2019)

Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review
por: Bashir, Aamir, et al.
Publicado: (2021)

Lysosomes and Lysosomal Storage Diseases
por: Noebels, Jeffrey L.
Publicado: (1981)

The use of port-a-caths in adult patients with Lysosomal Storage Disorders receiving Enzyme Replacement Therapy-one centre experience
por: McLoughlin, Mairead, et al.
Publicado: (2017)

Lysosomal storage diseases
por: Ferreira, Carlos R., et al.
Publicado: (2017)

Comparison between Nanoparticle Encapsulation and Surface Loading for Lysosomal Enzyme Replacement Therapy
por: Muntimadugu, Eameema, et al.
Publicado: (2022)

Engineering of GlcNAc-1-Phosphotransferase for Production of Highly Phosphorylated Lysosomal Enzymes for Enzyme Replacement Therapy
por: Liu, Lin, et al.
Publicado: (2017)

Mannose-6-phosphate glycan for lysosomal targeting: various applications from enzyme replacement therapy to lysosome-targeting chimeras
por: Seo, Jinho, et al.
Publicado: (2022)

Development of Organelle Replacement Therapy Using a Stearyl-Polyhistidine Peptide against Lysosomal Storage Disease Cells
por: Hayashi, Taiki, et al.
Publicado: (2019)

Biomarkers in Lysosomal Storage Diseases
por: Bobillo Lobato, Joaquin, et al.
Publicado: (2016)

Systematic review of economic evaluations of varicella vaccination programmes
por: Anderson, Robert, et al.
Publicado: (2023)

Health economic evaluation of gene replacement therapies: methodological issues and recommendations
por: Aballéa, Samuel, et al.
Publicado: (2020)

RTB Lectin: a novel receptor-independent delivery system for lysosomal enzyme replacement therapies
por: Acosta, Walter, et al.
Publicado: (2015)

Exploiting the diphtheria toxin internalization receptor enhances delivery of proteins to lysosomes for enzyme replacement therapy
por: Sugiman-Marangos, S. N., et al.
Publicado: (2020)

Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases
por: Poletto, Edina, et al.
Publicado: (2019)

Crossing the gates of Babylon: Brain-penetrating enzyme replacement for lysosomal disorders
por: Baldo, Guilherme
Publicado: (2023)

Lysosomal Storage Diseases—Regulating Neurodegeneration
por: Onyenwoke, Rob U., et al.
Publicado: (2016)

Neuroinflammatory paradigms in lysosomal storage diseases
por: Bosch, Megan E., et al.
Publicado: (2015)

Modeling Lysosomal Storage Diseases in the Zebrafish
por: Zhang, T., et al.
Publicado: (2020)

Therapeutic Approaches in Lysosomal Storage Diseases
por: Fernández-Pereira, Carlos, et al.
Publicado: (2021)

Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases
por: Oh, Doo-Byoung
Publicado: (2015)

Enzyme replacement therapy for Fabry disease: A systematic review and meta-analysis
por: Alegra, Taciane, et al.
Publicado: (2012)

Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease
por: Blumenreich, Shani, et al.
Publicado: (2020)

Lysosomal storage disorders
por: Cabrera-Salazar, Mario A, et al.
Publicado: (2007)

Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy
por: Cohen, Jennifer L., et al.
Publicado: (2019)

CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges
por: Edelmann, Mariola J., et al.
Publicado: (2020)

Gene therapy for lysosomal storage diseases: Current clinical trial prospects
por: Kido, Jun, et al.
Publicado: (2023)

The Cost-Effectiveness of Kidney Replacement Therapy Modalities: A Systematic Review of Full Economic Evaluations
por: Yang, Fei, et al.
Publicado: (2020)

The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells
por: Tian, Weihua, et al.
Publicado: (2019)

Recent advances in gene therapy for lysosomal storage disorders
por: Rastall, David PW, et al.
Publicado: (2015)

Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
por: Platt, Frances M., et al.
Publicado: (2012)

Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial—Lysosomal Axis
por: Kuk, Myeong Uk, et al.
Publicado: (2021)

Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy
por: Nordin, Sabrina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p0bk8ggd30eh18ee2ondv8oe67